Atos reported a weak opening to 2026 on Tuesday, delivering first-quarter comparable revenue of 1.64 billion euros, equivalent to an organic contraction of roughly 11% compared with the same period a year earlier.
Management attributed the decline in part to the deliberate exit of lower-margin contracts and to subdued activity in North America, where several customers took a wait-and-see posture that delayed decision-making. Those dynamics weighed on demand early in the year, producing the double-digit organic drop in revenue.
Despite the top-line weakness, the company said its commercial indicators are trending in a healthier direction. Atos reported that its book-to-bill ratio improved to 87% from 83% a year earlier, and that its qualified sales pipeline expanded by approximately 900 million euros over the quarter.
The group also highlighted tangible progress under its Genesis restructuring program. Management said the plan has achieved the cost savings it expected so far and that Genesis will be extended to extract further efficiencies going forward.
On guidance, Atos reaffirmed its overarching outlook for 2026 but tightened the range for organic revenue to a decline of 1% to 5%. That narrows a previous range that had allowed for potential growth while acknowledging a downside scenario of minus 5%. The company kept its operating margin target for the year at about 7%.
Looking beyond 2026, Atos reiterated expectations that growth will accelerate starting in 2027. The group is aiming for a compound annual revenue growth rate of 5% to 7% through 2028 and an operating margin near 10% by that time.
Contextual takeaways
- First-quarter comparable revenue: 1.64 billion euros, organic decline of about 11% year-on-year.
- Commercial momentum: book-to-bill rose to 87% from 83%; qualified pipeline increased by roughly 900 million euros during the quarter.
- Restructuring: Genesis delivered expected cost savings and will be extended to pursue additional efficiencies.
- Guidance: 2026 organic revenue narrowed to a decline of 1% to 5%; operating margin target maintained at around 7%.
- Medium-term targets: 5% to 7% revenue CAGR through 2028 and operating margin of about 10% by 2028.